Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo

The nef genes of the human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2) and the related simian immunodeficiency viruses (SIVs) encode a protein (Nef) whose role in virus replication and cytopathicity remains uncertain. As an attempt to elucidate the function of nef, we characterized the nucleotide and corresponding protein sequences of naturally occurring nef genes obtained from several HIV-1-infected individuals. A consensus Nef sequence was derived and used to identify several features that were highly conserved among the Nef sequences. These features included a nearly invariant myristylation signal, regions of sequence polymorphism and variable duplication, a region with an acidic charge, a (Pxx)4 repeat sequence, and a potential protein kinase C phosphorylation site. Clustering of premature stop codons at position 124 was noted in 6 of the 54 Nef sequences. Further analysis revealed four stretches of residues that were highly conserved not only among the patient-derived HIV-1 Nef sequences, but also among the Nef sequences of HIV-2 and the SIVs, suggesting that Nef proteins expressed by these retroviruses are functionally equivalent. The "Nef-defining" sequences were used to evaluate the sequence alignments of known proteins reported to share sequence similarity with Nef sequences and to conduct additional computer-based searches for similar protein sequences. A gene encoding the consensus Nef sequence was also generated. This gene encodes a full-length Nef protein that should be a valuable tool in further studies of Nef function.

[1]  R. Swanstrom,et al.  Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells , 1993, Journal of virology.

[2]  J. Garcia,et al.  The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4 , 1993, Journal of virology.

[3]  R. Desrosiers,et al.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.

[4]  Y. Takebe,et al.  Constitutive expression of the nef gene suppresses human immunodeficiency virus type 1 (HIV-1) replication in monocytic cell lines. , 1992, Virology.

[5]  A. Saah,et al.  Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Epstein,et al.  Human immunodeficiency virus type 1 nef quasispecies in pathological tissue , 1992, Journal of virology.

[7]  D. Richman,et al.  Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages. , 1992, The Journal of general virology.

[8]  M. Harris,et al.  In vivo derived HIV-1 nef gene products are heterogeneous and lack detectable nucleotide binding activity. , 1992, AIDS research and human retroviruses.

[9]  R. Germain,et al.  MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8 , 1992, Nature.

[10]  R. Gaynor,et al.  Cellular transcription factors involved in the regulation of HIV-1 gene expression. , 1992, AIDS.

[11]  G. Yu,et al.  Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. , 1992, Virology.

[12]  R. Gibbs,et al.  Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Burman,et al.  Nucleotide and amino acid homology between the human thyrotropin receptor and the HIV-1 Nef protein: identification and functional analysis. , 1991, Biochemical and biophysical research communications.

[14]  T. Werner,et al.  HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. , 1991, AIDS.

[15]  E. Krebs,et al.  Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. , 1991, The Journal of biological chemistry.

[16]  A. Meyerhans,et al.  Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo , 1991, Journal of virology.

[17]  T. Papas,et al.  Nef proteins of the human immunodeficiency viruses (HIV-1 and HIV-2) and simian immunodeficiency virus (SIV) are structurally similar to leucine zipper transcriptional activation factors. , 1991, AIDS research and human retroviruses.

[18]  S. Luria,et al.  Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Desrosiers,et al.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.

[20]  J. Garcia,et al.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef , 1991, Nature.

[21]  A. Meyerhans,et al.  Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes , 1991, Journal of virology.

[22]  N. Sarver,et al.  Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells , 1991, Journal of virology.

[23]  R. Cheynier,et al.  Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro , 1991, Journal of virology.

[24]  P. Simmonds,et al.  Edinburgh Research Explorer Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source , 2017 .

[25]  J. Lautenberger,et al.  Heterogeneity of Nef proteins in cells infected with human immunodeficiency virus type 1. , 1990, Virology.

[26]  B. Guy,et al.  Production of a non-functional nef protein in human immunodeficiency virus type 1-infected CEM cells. , 1990, Journal of General Virology.

[27]  C. Rosen,et al.  A rapid method for the construction of synthetic genes using the polymerase chain reaction. , 1990, BioTechniques.

[28]  J. Davide,et al.  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.

[29]  M. Reitz,et al.  Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages , 1990, Journal of virology.

[30]  B. Guy,et al.  Mutational analysis of the HIV nef protein. , 1990, Virology.

[31]  Temple F. Smith,et al.  Autoimmune response in AIDS , 1990, Nature.

[32]  P. Simmonds,et al.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers , 1990, Journal of virology.

[33]  Andreas Meyerhans,et al.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations , 1989, Cell.

[34]  G. Shaw,et al.  Extensive variation of human immunodeficiency virus type-1 in vivo , 1988, Nature.

[35]  David Looney,et al.  Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.

[36]  M. Simon,et al.  G protein multiplicity in eukaryotic signal transduction systems. , 1988, Biochemistry.

[37]  G. Mardon,et al.  The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant , 1988, Molecular and cellular biology.

[38]  Rodger Staden,et al.  Methods to define and locate patterns of motifs in sequences , 1988, Comput. Appl. Biosci..

[39]  B. Guy,et al.  HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product , 1987, Nature.

[40]  R. Flügel,et al.  The 3′‐orf protein of human immunodeficiency virus 2 shows sequence homology with the bel3 gene of the human spumaretrovirus , 1987, FEBS letters.

[41]  J. Lautenberger,et al.  The 3′‐orf protein of human immunodeficiency virus shows structural homology with the phosphorylation domain of human interleukin‐2 receptor and the ATP‐binding site of the protein kinase family , 1987, FEBS letters.

[42]  W. Merrick,et al.  GTP-binding domain: three consensus sequence elements with distinct spacing. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Cheng‐Mayer,et al.  Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Ghrayeb,et al.  Cytoplasmic localization of the HTLV-III 3' orf protein in cultured T cells. , 1986, Virology.

[45]  J. Sodroski,et al.  Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity , 1986, Journal of virology.

[46]  A. Miller,et al.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production , 1986, Molecular and cellular biology.

[47]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[48]  B. Hahn,et al.  Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. , 1985, Nucleic acids research.

[49]  J. Coligan,et al.  A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. , 1985, Science.

[50]  J. Devereux,et al.  A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..

[51]  M. O. Dayhoff,et al.  Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Lerner,et al.  Nucleotide sequence of Moloney murine leukaemia virus , 1981, Nature.

[53]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Guardiola,et al.  Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. , 1992, Nature.

[55]  A. Hovanessian On the HIV nef gene product. , 1992, Research in virology.

[56]  B. Cullen Regulation of human immunodeficiency virus replication. , 1991, Annual review of microbiology.

[57]  A. Miller,et al.  Improved retroviral vectors for gene transfer and expression. , 1989, BioTechniques.

[58]  R. Gilcher Human retroviruses and AIDS. , 1988, The Journal of the Oklahoma State Medical Association.

[59]  L. Jagodzinski,et al.  Complete nucleotide sequences of functional clones of the AIDS virus. , 1987, AIDS research and human retroviruses.

[60]  P. Y. Chou,et al.  Empirical predictions of protein conformation. , 1978, Annual review of biochemistry.

[61]  M. O. Dayhoff A model of evolutionary change in protein , 1978 .

[62]  M. O. Dayhoff,et al.  22 A Model of Evolutionary Change in Proteins , 1978 .